Study Reference No. - C1D00719
| Study Reference No. | Study Type | Compensation | Gender | Age | Demographic |
|---|---|---|---|---|---|
| C1D00719 | Healthy | $2,625 | Males and Females | 18-65 | Vasectomized or infertile males;
Non-childbearing females (surgical removal of reproductive parts or post-menopausal; Non-smokers for at least the past 6 months |
Study Details |
|
Study Purpose |
The purpose of this study is to evaluate the safety, tolerability and the amount of the study drug in your blood of VIRAZOLE (Ribavirin for Inhalation Solution, USP) in healthy volunteers. |
Study Duration |
Approx. 40 days total; 1 Period with 2 overnight stays and 2 returns |
Study Schedule |
|
General Screening |
NA |
Medical Screening |
Multiple screening dates starting March 12; contact Recruitment |
Study Visit(s) |
Multiple cohort dates starting March 23; contact Recruitment |
Follow-Up Visit(s) |
NA |
Other Notes |
|
Bring Valid Photo ID. COVID-19 test will be conducted prior to check-in. |
|